{"id":"hrs-7535-tablet","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Due to limited information, the exact mechanism of HRS-7535 tablet is unknown.","oneSentence":"HRS-7535 tablet's mechanism of action is not publicly available.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:45:47.989Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06415214","phase":"PHASE2","title":"Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes","status":"COMPLETED","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-06-21","conditions":"Diabetic Kidney Disease, Type 2 Diabetes","enrollment":281},{"nctId":"NCT07269756","phase":"PHASE1","title":"A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2025-12-08","conditions":"Obesity, Overweight","enrollment":40},{"nctId":"NCT06820099","phase":"PHASE2","title":"Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2025-04-10","conditions":"Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity","enrollment":225},{"nctId":"NCT06393348","phase":"PHASE2","title":"Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.","status":"COMPLETED","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-05-17","conditions":"Type 2 Diabetes","enrollment":155},{"nctId":"NCT06671821","phase":"PHASE2","title":"Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects","status":"COMPLETED","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-11-20","conditions":"Chronic Weight Management","enrollment":81},{"nctId":"NCT06904105","phase":"PHASE3","title":"A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2025-04-09","conditions":"Overweight, Obesity","enrollment":556},{"nctId":"NCT06672172","phase":"PHASE3","title":"A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-09-25","conditions":"Type 2 Diabetes","enrollment":284},{"nctId":"NCT06621316","phase":"PHASE1, PHASE2","title":"A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-10-30","conditions":"Overweight or Obesity","enrollment":74},{"nctId":"NCT06250946","phase":"PHASE2","title":"Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .","status":"COMPLETED","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-02-23","conditions":"Overweight and Obesity","enrollment":235},{"nctId":"NCT06589765","phase":"PHASE3","title":"A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-09-27","conditions":"Type 2 Diabetes","enrollment":800},{"nctId":"NCT06727838","phase":"PHASE1","title":"Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human","status":"NOT_YET_RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-12","conditions":"Diabetes","enrollment":54},{"nctId":"NCT06132204","phase":"PHASE1","title":"Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects","status":"COMPLETED","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2023-12-21","conditions":"Type 2 Diabetes","enrollment":16},{"nctId":"NCT06495931","phase":"PHASE1","title":"Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human","status":"NOT_YET_RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-07","conditions":"Type 2 Diabetes Mellitus","enrollment":24},{"nctId":"NCT06422039","phase":"PHASE1","title":"Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects","status":"NOT_YET_RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-05-15","conditions":"Type 2 Diabetes Mellitus","enrollment":18}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"HRS-7535 tablet","genericName":"HRS-7535 tablet","companyName":"Shandong Suncadia Medicine Co., Ltd.","companyId":"shandong-suncadia-medicine-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}